This feels like a very lazy way of writing a blog – but I do not believe in re-inventing the wheel so, if Alex has already said it, and said it well, why would I say it again? In fact, on this occasion, it is not only Alex but one of his ‘commenters’, GlutenfreeB, who has said it particularly well. But, as a coeliac and a consultant to pharmaceutical companies, she in the ideal place to do so.
The drugs concerned are ‘Larazotide acetate, developed by Alba Therapeutics, the brainchild of coeliac expert Dr Alessio Fasano, and Latiglutenase developed by ALV003 by Alvine Pharmaceuticals. Larazotide acetate is meant to make the gut less ‘leaky’ so less likely to allow small fractions of gluten through and protect coeliacs against accidental low level gluten contamination; Latiglutenase is an enzyme devised to break down gluten proteins into harmless fractions in the small intestine. So now, read on, courtesy of Food Allergy and Intolerance Ink….